Amy Feng

1.2k total citations
38 papers, 743 citations indexed

About

Amy Feng is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Amy Feng has authored 38 papers receiving a total of 743 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 6 papers in Surgery. Recurrent topics in Amy Feng's work include Bone health and treatments (8 papers), Cancer Treatment and Pharmacology (5 papers) and Bone Tumor Diagnosis and Treatments (5 papers). Amy Feng is often cited by papers focused on Bone health and treatments (8 papers), Cancer Treatment and Pharmacology (5 papers) and Bone Tumor Diagnosis and Treatments (5 papers). Amy Feng collaborates with scholars based in United States, Canada and Australia. Amy Feng's co-authors include Shuxian Hu, Wen S. Sheng, R. Bryan Rock, R. J. Grimer, Bruce Allen Bach, Leanne L. Seeger, Zachary Roberts, Roger von Moos, Saroj Vadhan‐Raj and Stefano Ferrari and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Amy Feng

32 papers receiving 728 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amy Feng United States	12	227	223	219	148	134	38	743
Saral Desai India	16	126 0.6×	496 2.2×	273 1.2×	38 0.3×	113 0.8×	56	957
Hye‐Rim Park South Korea	15	82 0.4×	179 0.8×	162 0.7×	40 0.3×	106 0.8×	51	625
Fehmi Mercanoğlu Türkiye	19	56 0.2×	157 0.7×	98 0.4×	17 0.1×	121 0.9×	36	902
P. De Nayer Belgium	16	185 0.8×	163 0.7×	62 0.3×	107 0.7×	169 1.3×	26	870
Elena Ceccarelli Italy	17	79 0.3×	81 0.4×	178 0.8×	13 0.1×	214 1.6×	25	1.2k
Refik Tanakol Türkiye	17	96 0.4×	98 0.4×	86 0.4×	27 0.2×	180 1.3×	50	871
Hassan Zmerly Italy	6	177 0.8×	483 2.2×	415 1.9×	10 0.1×	152 1.1×	23	857
L.R. Bégin Canada	15	153 0.7×	295 1.3×	130 0.6×	31 0.2×	109 0.8×	32	732
Kayo Tanaka Japan	16	127 0.6×	84 0.4×	170 0.8×	19 0.1×	123 0.9×	73	1.1k
Haydar Durak Türkiye	15	95 0.4×	136 0.6×	77 0.4×	19 0.1×	132 1.0×	43	503

Countries citing papers authored by Amy Feng

Since Specialization

Citations

This map shows the geographic impact of Amy Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Feng more than expected).

Fields of papers citing papers by Amy Feng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Feng. The network helps show where Amy Feng may publish in the future.

Co-authorship network of co-authors of Amy Feng

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Feng. A scholar is included among the top collaborators of Amy Feng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Feng. Amy Feng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Locke, Frederick L., Javier Muñoz, Michael Tees, et al.. (2025). Allogeneic Chimeric Antigen Receptor T-Cell Products Cemacabtagene Ansegedleucel/ALLO-501 in Relapsed/Refractory Large B-Cell Lymphoma: Phase I Experience From the ALPHA2/ALPHA Clinical Studies. Journal of Clinical Oncology. 43(14). 1695–1705. 11 indexed citations

Ahmad, Syed A., Andrew Kalra, Amy Feng, et al.. (2025). Characteristics and risk factors of delirium in patients on veno-arterial extracorporeal membrane oxygenation. Perfusion. 40(8). 1762–1771.

Ahmad, Syed A., Amy Feng, Andrew Kalra, et al.. (2025). Prevalence and characteristics of acute ischemic stroke and intracranial hemorrhage in patients with immune thrombocytopenic purpura and immune thrombotic thrombocytopenic purpura: a systematic review and meta-analysis. Neurological Research and Practice. 7(1). 19–19.

Gold, Linda Stein, Javier Alonso‐Llamazares, Zoe Draelos, et al.. (2022). Effect of Roflumilast Cream (ARQ-151) on Itch and Itch-Related Sleep Loss in Adults with Chronic Plaque Psoriasis: Patient-Reported Itch Outcomes of a Phase 2b Trial. American Journal of Clinical Dermatology. 24(2). 305–313. 9 indexed citations

Gunn, Laura H., Ailsa McKay, Amy Feng, et al.. (2022). Estimated cardiovascular benefits of bempedoic acid in patients with established cardiovascular disease. SHILAP Revista de lepidopterología. 49. 20–27. 10 indexed citations

Gold, Linda Stein, Jerry Bagel, J.Q. Del Rosso, et al.. (2022). 33463 Pooled efficacy and safety results from the DERMIS-1 and DERMIS-2 phase 3 trials of once-daily roflumilast cream 0.3% by baseline body surface area. Journal of the American Academy of Dermatology. 87(3). AB192–AB192.

Ray, Kausik K., Laura H. Gunn, Ailsa McKay, et al.. (2021). ESTIMATED CARDIOVASCULAR BENEFITS OF BEMPEDOIC ACID IN PATIENTS WITH ESTABLISHED CARDIOVASCULAR DISEASE. Journal of the American College of Cardiology. 77(18). 1460–1460. 3 indexed citations

Engellau, Jacob, Leanne L. Seeger, R. J. Grimer, et al.. (2018). Assessment of denosumab treatment effects and imaging response in patients with giant cell tumor of bone. World Journal of Surgical Oncology. 16(1). 191–191. 39 indexed citations

Lüchters, Stanley, Amy Feng, Marlise Richter, et al.. (2016). “A Baby Was an Added Burden”: Predictors and Consequences of Unintended Pregnancies for Female Sex Workers in Mombasa, Kenya: A Mixed-Methods Study. PLoS ONE. 11(9). e0162871–e0162871. 55 indexed citations

10.

Adatya, Sirtaz, Christopher T. Holley, Samit S. Roy, et al.. (2015). Echocardiographic Ramp Test for Continuous-Flow Left Ventricular Assist Devices. JACC Heart Failure. 3(4). 291–299. 16 indexed citations

11.

Feng, Amy, et al.. (2015). Uterine Papillary Serous Carcinoma. International Journal of Gynecological Cancer. 26(1). 133–140. 19 indexed citations

12.

Rutkowski, Piotr, Stefano Ferrari, R. J. Grimer, et al.. (2015). Surgical Downstaging in an Open-Label Phase II Trial of Denosumab in Patients with Giant Cell Tumor of Bone. Annals of Surgical Oncology. 22(9). 2860–2868. 129 indexed citations

13.

Adatya, Sirtaz, Nir Uriel, Hirad Yarmohammadi, et al.. (2015). Anti–Factor Xa and Activated Partial Thromboplastin Time Measurements for Heparin Monitoring in Mechanical Circulatory Support. JACC Heart Failure. 3(4). 314–322. 40 indexed citations

14.

Diel, Ingo, Jean‐Jacques Body, Alison Stopeck, et al.. (2015). The role of denosumab in the prevention of hypercalcaemia of malignancy in cancer patients with metastatic bone disease. European Journal of Cancer. 51(11). 1467–1475. 34 indexed citations

15.

Martín‐Broto, Javier, Charles S. Cleeland, Paul Glare, et al.. (2014). Effects of denosumab on pain and analgesic use in giant cell tumor of bone: Interim results from a phase II study. Acta Oncologica. 53(9). 1173–1179. 54 indexed citations

16.

Henry, David H., Saroj Vadhan‐Raj, Vera Hirsh, et al.. (2013). Delaying skeletal-related events in a randomized phase 3 study of denosumab versus zoledronic acid in patients with advanced cancer: an analysis of data from patients with solid tumors. Supportive Care in Cancer. 22(3). 679–687. 130 indexed citations

17.

Sheng, Wen S., Shuxian Hu, Amy Feng, & R. Bryan Rock. (2013). Reactive Oxygen Species from Human Astrocytes Induced Functional Impairment and Oxidative Damage. Neurochemical Research. 38(10). 2148–2159. 92 indexed citations

18.

Patrick, Donald L., Charles S. Cleeland, Lesley Fallowfield, et al.. (2011). 711 EFFECTS OF DENOSUMAB AND ZOLEDRONIC ACID ON PAIN INTERFERENCE WITH DAILY FUNCTIONING IN PATIENTS WITH CASTRATE-RESISTANT PROSTATE CANCER. The Journal of Urology. 185(4S). 3 indexed citations

19.

Jorgenson, James A., Philip E. Johnson, Donald F. Brophy, et al.. (2008). Use and prescribing patterns for erythropoiesis-stimulating agents in inpatient and outpatient hospital settings. American Journal of Health-System Pharmacy. 65(18). 1711–1719. 11 indexed citations

20.

Brown, Mary E., et al.. (2000). Effects of Various Treatments on the Quantitative Recovery of Endotoxin from Water-Soluble Metalworking Fluids. PubMed. 61(4). 517–520. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact